Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • One Bridge Plaza
  • Fort Lee, NJ 07024

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2011 10-Q
CIK 0000356591
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Adrian Adams CEO
Andrew Koven President, Chief Admin. Officer
Reginald A. Hardy Vice President
Company Directors
Adrian Adams Chairman
Reginald A. Hardy
Clark A. Johnson
Andrew Koven
Company Notes
  • Note=2-04 company is in the development stage, developing proprietary gene therapies for treating central nervous system disorders
  • Formerly=Change Technology Partners, Inc. until 2-04
  • Note=9-00 State of Incorporation New Mexico changed to Delaware concurrent with name change
  • Formerly=Arinco Computer Systems, Inc until 9-00
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
NRGXQ Security Details
Share Structure
Market Value1 $50,396 a/o Aug 18, 2017
Authorized Shares Not Available
Outstanding Shares 27,997,701 a/o May 01, 2011
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Shareholders of Record 268 a/o Mar 25, 2011
Short Selling Data
Short Interest 0 (-100%)
Nov 13, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security